Article ID Journal Published Year Pages File Type
3906645 Urology 2006 5 Pages PDF
Abstract
Judicious broadening of the clinical selection criteria may allow a greater number of patients to be eligible for permanent prostate brachytherapy monotherapy by including patients whose risk of having adverse pathologic features is comparable to that of patients currently deemed suitable for permanent prostate brachytherapy monotherapy. Prospective assessment of oncologic outcomes of such an approach is required.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , , , , , , ,